Literature DB >> 18457531

Vascular risk factors and Alzheimer's disease.

David F Cechetto1, Vladimir Hachinski, Shawn N Whitehead.   

Abstract

Vascular cognitive impairment risk factors include stroke, hypertension, diabetes and atherosclerosis. In the elderly, vascular risk factors occur in the presence of high levels of amyloid in the aging brain. Stroke alters the clinical expression of a given load of Alzheimer's disease (AD) pathology. Experimentally, large vessel infarcts or small striatal infarcts are larger in the presence of amyloid. Patients with minor cerebral infarcts and moderate AD lesions will develop the clinical manifestations of dementia. Moreover, there is also an association between other vascular risk factors and the clinical expression of cognitive decline and dementia. The risk of AD is increased in subjects with adult-onset diabetes mellitus, hypertension, atherosclerotic disease and atrial fibrillation. Experimentally, small striatal infarcts in the presence of high levels of amyloid in the brain exhibit a progression in infarct size over time with enhanced degree of cognitive impairment, AD-type pathology and neuroinflammation compared with striatal infarcts or high amyloid levels alone.

Entities:  

Mesh:

Year:  2008        PMID: 18457531     DOI: 10.1586/14737175.8.5.743

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  42 in total

1.  AVR/NAVR deficiency lowers blood pressure and differentially affects urinary concentrating ability, cognition, and anxiety-like behavior in male and female mice.

Authors:  Victoria L M Herrera; Pia Bagamasbad; Julius L Decano; Nelson Ruiz-Opazo
Journal:  Physiol Genomics       Date:  2010-10-05       Impact factor: 3.107

2.  The association of genetic variants in interleukin-1 genes with cognition: findings from the cardiovascular health study.

Authors:  K S Benke; M C Carlson; B Q Doan; J D Walston; Q L Xue; A P Reiner; L P Fried; D E Arking; A Chakravarti; M D Fallin
Journal:  Exp Gerontol       Date:  2011-09-24       Impact factor: 4.032

3.  Therapy for Alzheimer's Disease: How Effective are Current Treatments?

Authors:  Krista L Lanctôt; Ryan D Rajaram; Nathan Herrmann
Journal:  Ther Adv Neurol Disord       Date:  2009-05       Impact factor: 6.570

4.  Apolipoprotein E genotyping and questionnaire-based assessment of lifestyle risk factors in dyslipidemic patients with a family history of Alzheimer's disease: test development for clinical application.

Authors:  H K Lückhoff; M Kidd; S J van Rensburg; D P van Velden; M J Kotze
Journal:  Metab Brain Dis       Date:  2016-02       Impact factor: 3.584

5.  Coronary artery disease is associated with cognitive decline independent of changes on magnetic resonance imaging in cognitively normal elderly adults.

Authors:  Ling Zheng; Wendy J Mack; Helena C Chui; Lara Heflin; Dan Mungas; Bruce Reed; Charles DeCarli; Michael W Weiner; Joel H Kramer
Journal:  J Am Geriatr Soc       Date:  2012-01-27       Impact factor: 5.562

6.  Assessment of the Virchow-Robin Spaces in Alzheimer disease, mild cognitive impairment, and normal aging, using high-field MR imaging.

Authors:  W Chen; X Song; Y Zhang
Journal:  AJNR Am J Neuroradiol       Date:  2011-07-14       Impact factor: 3.825

Review 7.  Viral vectors for therapy of neurologic diseases.

Authors:  Sourav R Choudhury; Eloise Hudry; Casey A Maguire; Miguel Sena-Esteves; Xandra O Breakefield; Paola Grandi
Journal:  Neuropharmacology       Date:  2016-02-21       Impact factor: 5.250

8.  Cognitive Consequences of Aging with HIV: Implications for Neuroplasticity and Rehabilitation.

Authors:  David E Vance; Graham J McDougall; Natalie Wilson; Marcus Otavio Debiasi; Shameka L Cody
Journal:  Top Geriatr Rehabil       Date:  2014-01

9.  The association between small vessel infarcts and the activities of amyloid-β peptide degrading proteases in apolipoprotein E4 allele carriers.

Authors:  Haihao Zhu; Rafeeque A Bhadelia; Zhiheng Liu; Linh Vu; Huajie Li; Tammy Scott; Peter Bergethon; Mkaya Mwamburi; James L Rosenzweig; Irwine Rosenberg; Wei Qiao Qiu
Journal:  Angiology       Date:  2012-10-17       Impact factor: 3.619

10.  Epidemiological pathology of dementia: attributable-risks at death in the Medical Research Council Cognitive Function and Ageing Study.

Authors:  Fiona E Matthews; Carol Brayne; James Lowe; Ian McKeith; Stephen B Wharton; Paul Ince
Journal:  PLoS Med       Date:  2009-11-10       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.